Regeneron Pharmaceuticals
REGN
#268
Rank
C$113.64 B
Marketcap
C$1,072
Share price
1.59%
Change (1 day)
4.85%
Change (1 year)

Earnings for Regeneron Pharmaceuticals (REGN)

Earnings in 2025 (TTM): C$7.19 Billion

According to Regeneron Pharmaceuticals's latest financial reports the company's current earnings are C$14.24 Billion. In 2024 the company made an earning of C$6.56 Billion, an increase over its 2023 earnings that were of C$5.77 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Regeneron Pharmaceuticals from 1990 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) C$7.19 B9.57%
2024 C$6.56 B13.83%
2023 C$5.77 B-13.57%
2022 C$6.67 B-47.9%
2021 C$12.81 B144.75%
2020 C$5.23 B56.86%
2019 C$3.33 B-4.87%
2018 C$3.50 B22.86%
2017 C$2.85 B56.3%
2016 C$1.82 B8.55%
2015 C$1.68 B54.53%
2014 C$1.08 B11.14%
2013 C$0.98 B72.13%
2012 C$0.56 B-285.93%
2011 -C$0.31 Billion121.73%
2010 -C$0.14 Billion37.18%
2009 -C$0.11 Billion-14.6%
2008 -C$0.12 Billion-25.02%
2007 -C$0.16 Billion6.32%
2006 -C$0.15 Billion-186.52%
2005 C$0.17 B2103.7%
2004 C$7.76 M-105.66%
2003 -C$0.14 Billion-18.18%
2002 -C$0.17 Billion42.33%
2001 -C$0.12 Billion129.35%
2000 -C$51.35 Million51.87%
1999 -C$33.82 Million92.19%
1998 -C$17.6 Million66.23%
1997 -C$10.59 Million-55.49%
1996 -C$23.78 Million103.53%
1995 -C$11.69 Million-70.89%
1994 -C$40.14 Million-26.08%
1993 -C$54.3 Million114.67%
1992 -C$25.29 Million196.77%
1991 -C$8.53 Million87.88%
1990 -C$4.54 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
C$11.33 B 60.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
C$0.17 B-97.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
C$2.61 B-62.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
C$44.52 B 529.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$22.56 B 219.12%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
C$12.50 B 76.87%๐Ÿ‡ซ๐Ÿ‡ท France